All News about Biodesix Inc
Via Benzinga
Biodesix Announces First Four Private Payer Coverage Policies for the Nodify XL2® Test
December 19, 2022
From Biodesix, Inc.
Via Business Wire
Biodesix's Return On Capital Employed Insights
November 22, 2022
Via Benzinga
Biodesix Announces Appointment of Lawrence (Lair) T. Kennedy, Jr. to Board of Directors
December 16, 2022
From Biodesix, Inc.
Via Business Wire
From Biodesix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
December 01, 2022
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 01, 2022
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 30, 2022
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 17, 2022
Via Benzinga
Biodesix Announces Pricing of $35.1 Million Upsized Public Offering of Common Stock
November 17, 2022
From Biodesix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 16, 2022
Via Benzinga
Biodesix Announces Proposed Public Offering of Common Stock
November 16, 2022
From Biodesix, Inc.
Via Business Wire
Biodesix Announces Third Quarter 2022 Results and Highlights
November 03, 2022
From Biodesix, Inc.
Via Business Wire
From Biodesix, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.